Nuclear translocation of heparan sulfate proteoglycans and their functional significance

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 8, 2014, Pages 2491-2497

  Kovalszky, Ilona ^a   Hjerpe, Anders ^b   Dobra, Katalin ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gene transcription; Heparan sulfate; Nuclear translocation; Proliferation; Proteoglycan

Indexed keywords

DNA TOPOISOMERASE; FIBROBLAST GROWTH FACTOR 2; GLYPICAN; HERMES ANTIGEN; PERLECAN; PROTEOHEPARAN SULFATE; SYNDECAN;

CELL CYCLE PROGRESSION; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; ENZYME INHIBITION; HUMAN; MACROMOLECULE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION TERMINATION;

GENE TRANSCRIPTION; HEPARAN SULFATE; NUCLEAR TRANSLOCATION; PROLIFERATION; PROTEOGLYCAN;

ANIMALS; CELL NUCLEUS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; PROTEIN TRANSPORT; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84903438935     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.04.015     Document Type: Review

References (114)

1. S. Reitsma, D.W. Slaaf, H. Vink, M.A. van Zandvoort, and M.G. oude Egbrink The endothelial glycocalyx: composition, functions, and visualization Pflugers Arch. Eur. J. Physiol. 454 2007 345 359
2. E. Jorpes The chemistry of heparin Biochem. J. 29 1935 1817 1830
3. X. Lin Functions of heparan sulfate proteoglycans in cell signaling during development Development 131 2004 6009 6021
4. R.V. Iozzo, and R.D. Sanderson Proteoglycans in cancer biology, tumour microenvironment and angiogenesis J. Cell. Mol. Med. 15 2011 1013 1031
5. M.L. Fitzgerald, Z. Wang, P.W. Park, G. Murphy, and M. Bernfield Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase J. Cell Biol. 148 2000 811 824
6. A. Woods, R.L. Longley, S. Tumova, and J.R. Couchman Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts Arch. Biochem. Biophys. 374 2000 66 72
7. A. Yoneda, and J.R. Couchman Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans Matrix Biol. 22 2003 25 33
8. M. Gotte Syndecans in inflammation FASEB J. 17 2003 575 591
9. J. Schlessinger, A.N. Plotnikov, O.A. Ibrahimi, A.V. Eliseenkova, B.K. Yeh, A. Yayon, R.J. Linhardt, and M. Mohammadi Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization Mol. Cell 6 2000 743 750
10. D.J. Carey Syndecans: multifunctional cell-surface co-receptors Biochem. J. 327 Pt 1 1997 1 16
11. X. Xian, S. Gopal, and J.R. Couchman Syndecans as receptors and organizers of the extracellular matrix Cell Tissue Res. 2009
12. D.M. Ornitz FGFs, heparan sulfate and FGFRs: complex interactions essential for development Bioessays 22 2000 108 112
13. S. Kinoshita Some observations on a protein-mucopolysaccharide complex found in sea urchin embryos Exp. Cell Res. 85 1974 31 40
14. C.T. Warnick, and H.M. Zazarus Stimulation of transcription of mouse kidney chromatin by sulfated polysaccharides Nucleic Acids Res. 2 1975 735 744
15. R.K. Margolis, C.P. Crockett, W.L. Kiang, and R.U. Margolis Glycosaminoglycans and glycoproteins associated with rat brain nuclei Biochim. Biophys. Acta 451 1976 465 469
16. V.P. Bhavanandan, and E.A. Davidson Mucopolysaccharides associated with nuclei of cultured mammalian cells Proc. Natl. Acad. Sci. U. S. A. 72 1975 2032 2036
17. N.S. Fedarko, and H.E. Conrad A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells J. Cell Biol. 102 1986 587 599
18. M. Ishihara, N.S. Fedarko, and H.E. Conrad Transport of heparan sulfate into the nuclei of hepatocytes J. Biol. Chem. 261 1986 13575 13580
19. N.S. Fedarko, M. Ishihara, and H.E. Conrad Control of cell division in hepatoma cells by exogenous heparan sulfate proteoglycan J. Cell. Physiol. 139 1989 287 294
20. S.J. Busch, G.A. Martin, R.L. Barnhart, M. Mano, A.D. Cardin, and R.L. Jackson Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription J. Cell Biol. 116 1992 31 42
21. I. Kovalszky, J. Dudas, J. Olah-Nagy, G. Pogany, J. Tovary, J. Timar, L. Kopper, A. Jeney, and R.V. Iozzo Inhibition of DNA topoisomerase I activity by heparan sulfate and modulation by basic fibroblast growth factor Mol. Cell. Biochem. 183 1998 11 23
22. F. Cheng, P. Petersson, Y. Arroyo-Yanguas, and G. Westergren-Thorsson Differences in the uptake and nuclear localization of anti-proliferative heparan sulfate between human lung fibroblasts and human lung carcinoma cells J. Cell. Biochem. 83 2001 597 606
23. U. Brockstedt, K. Dobra, M. Nurminen, and A. Hjerpe Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: tubulin-dependent rearrangements Exp. Cell Res. 274 2002 235 245
24. T.P. Richardson, V. Trinkaus-Randall, and M.A. Nugent Regulation of heparan sulfate proteoglycan nuclear localization by fibronectin J. Cell Sci. 114 2001 1613 1623
25. S. Saunders, M. Jalkanen, S. O'Farrell, and M. Bernfield Molecular cloning of syndecan, an integral membrane proteoglycan J. Cell Biol. 108 1989 1547 1556
26. N. Perrimon, and M. Bernfield Cellular functions of proteoglycans - an overview Semin. Cell Dev. Biol. 12 2001 65 67
27. C. Seidel, A. Sundan, M. Hjorth, I. Turesson, I.M. Dahl, N. Abildgaard, A. Waage, and M. Borset Serum syndecan-1: a new independent prognostic marker in multiple myeloma Blood 95 2000 388 392
28. H. Joensuu, A. Anttonen, M. Eriksson, R. Makitaro, H. Alfthan, V. Kinnula, and S. Leppa Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer Cancer Res. 62 2002 5210 5217
29. T.P. Vassilakopoulos, M.C. Kyrtsonis, A. Papadogiannis, G. Nadali, M.K. Angelopoulou, T. Tzenou, M.N. Dimopoulou, M.P. Siakantaris, F.N. Kontopidou, C. Kalpadakis, S.I. Kokoris, E.M. Dimitriadou, P. Tsaftaridis, G. Pizzolo, and G.A. Pangalis Serum levels of soluble syndecan-1 in Hodgkin's lymphoma Anticancer Res. 25 2005 4743 4746
30. C.W. Kim, O.A. Goldberger, R.L. Gallo, and M. Bernfield Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns Mol. Biol. Cell 5 1994 797 805
31. P. Marynen, J. Zhang, J.J. Cassiman, H. Van den Berghe, and G. David Partial primary structure of the 48- and 90-kilodalton core proteins of cell surface-associated heparan sulfate proteoglycans of lung fibroblasts. Prediction of an integral membrane domain and evidence for multiple distinct core proteins at the cell surface of human lung fibroblasts J. Biol. Chem. 264 1989 7017 7024
32. D.J. Carey, D.M. Evans, R.C. Stahl, V.K. Asundi, K.J. Conner, P. Garbes, and G. Cizmeci-Smith Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan J. Cell Biol. 117 1992 191 201
33. S.E. Gould, W.B. Upholt, and R.A. Kosher Syndecan 3: a member of the syndecan family of membrane-intercalated proteoglycans that is expressed in high amounts at the onset of chicken limb cartilage differentiation Proc. Natl. Acad. Sci. U. S. A. 89 1992 3271 3275
34. G. David, B. van der Schueren, P. Marynen, J.J. Cassiman, and H. van den Berghe Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells J. Cell Biol. 118 1992 961 969
35. T. Kojima, N.W. Shworak, and R.D. Rosenberg Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line J. Biol. Chem. 267 1992 4870 4877
36. W.E. Leadbeater, A.M. Gonzalez, N. Logaras, M. Berry, J.E. Turnbull, and A. Logan Intracellular trafficking in neurones and glia of fibroblast growth factor-2, fibroblast growth factor receptor 1 and heparan sulphate proteoglycans in the injured adult rat cerebral cortex J. Neurochem. 96 2006 1189 1200
37. Y.M. Schrage, L. Hameetman, K. Szuhai, A.M. Cleton-Jansen, A.H. Taminiau, P.C. Hogendoorn, and J.V. Bovee Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma Am. J. Pathol. 174 2009 979 988
38. Y. Liang, M. Haring, P.J. Roughley, R.K. Margolis, and R.U. Margolis Glypican and biglycan in the nuclei of neurons and glioma cells: presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle J. Cell Biol. 139 1997 851 864
39. M. Bernfield, M. Gotte, P.W. Park, O. Reizes, M.L. Fitzgerald, J. Lincecum, and M. Zako Functions of cell surface heparan sulfate proteoglycans Annu. Rev. Biochem. 68 1999 729 777
40. A.N. Alexopoulou, H.A. Multhaupt, and J.R. Couchman Syndecans in wound healing, inflammation and vascular biology Int. J. Biochem. Cell Biol. 39 2007 505 528
41. A. Woods, and J.R. Couchman Syndecan-4 and focal adhesion function Curr. Opin. Cell Biol. 13 2001 578 583
42. P. Zimmermann, Z. Zhang, G. Degeest, E. Mortier, I. Leenaerts, C. Coomans, J. Schulz, F. N'Kuli, P.J. Courtoy, and G. David Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6 Dev. Cell 9 2005 377 388
43. N.M. Hooper, E.H. Karran, and A.J. Turner Membrane protein secretases Biochem. J. 321 Pt 2 1997 265 279
44. M. Yanagishita, and V.C. Hascall Cell surface heparan sulfate proteoglycans J. Biol. Chem. 267 1992 9451 9454
45. K. Lambaerts, S.A. Wilcox-Adelman, and P. Zimmermann The signaling mechanisms of syndecan heparan sulfate proteoglycans Curr. Opin. Cell Biol. 21 2009 662 669
46. Y. Yang, V. Macleod, H.Q. Miao, A. Theus, F. Zhan, J.D. Shaughnessy Jr., J. Sawyer, J.P. Li, E. Zcharia, I. Vlodavsky, and R.D. Sanderson Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis J. Biol. Chem. 282 2007 13326 13333
47. A. Purushothaman, L. Chen, Y. Yang, and R.D. Sanderson Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma J. Biol. Chem. 283 2008 32628 32636
48. V. Nikolova, C.Y. Koo, S.A. Ibrahim, Z. Wang, D. Spillmann, R. Dreier, R. Kelsch, J. Fischgrabe, M. Smollich, L.H. Rossi, W. Sibrowski, P. Wulfing, L. Kiesel, G.W. Yip, and M. Gotte Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression Carcinogenesis 30 2009 397 407
49. J. Filmus Glypicans in growth control and cancer Glycobiology 11 2001 19R 23R
50. R.V. Iozzo Perlecan: a gem of a proteoglycan Matrix Biol. 14 1994 203 208
51. M. Mongiat, S.M. Sweeney, J.D. San Antonio, J. Fu, and R.V. Iozzo Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan J. Biol. Chem. 278 2003 4238 4249
52. M. Arese, Y. Chen, R.Z. Florkiewicz, A. Gualandris, B. Shen, and D.B. Rifkin Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals Mol. Biol. Cell 10 1999 1429 1444
53. L.Y. Bourguignon, G. Wong, C. Earle, and L. Chen Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma J. Biol. Chem. 287 2012 32800 32824
54. M. Janiszewska, C. De Vito, M.A. Le Bitoux, C. Fusco, and I. Stamenkovic Transportin regulates nuclear import of CD44 J. Biol. Chem. 285 2010 30548 30557
55. S.A. Adam Transport pathways of macromolecules between the nucleus and the cytoplasm Curr. Opin. Cell Biol. 11 1999 402 406
56. J. Moroianu Nuclear import and export pathways J. Cell. Biochem. Suppl. 32-33 1999 76 83
57. E. Duverger, C. Pellerin-Mendes, R. Mayer, A.C. Roche, and M. Monsigny Nuclear import of glycoconjugates is distinct from the classical NLS pathway J. Cell Sci. 108 Pt 4 1995 1325 1332
58. F. Zong, E. Fthenou, N. Wolmer, P. Hollosi, I. Kovalszky, L. Szilak, C. Mogler, G. Nilsonne, G. Tzanakakis, and K. Dobra Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells PLoS One 4 2009 e7346
59. F. Zong, E. Fthenou, F. Mundt, T. Szatmari, I. Kovalszky, L. Szilak, D. Brodin, G. Tzanakakis, A. Hjerpe, and K. Dobra Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration PLoS One 6 2011 e14816
60. M. Belting, K. Mani, M. Jonsson, F. Cheng, S. Sandgren, S. Jonsson, K. Ding, J.G. Delcros, and L.A. Fransson Glypican-1 is a vehicle for polyamine uptake in mammalian cells: a pivotal role for nitrosothiol-derived nitric oxide J. Biol. Chem. 278 2003 47181 47189
61. J.L. Lee, M.J. Wang, and J.Y. Chen Acetylation and activation of STAT3 mediated by nuclear translocation of CD44 J. Cell Biol. 185 2009 949 957
62. E. Hsia, T.P. Richardson, and M.A. Nugent Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling J. Cell. Biochem. 88 2003 1214 1225
63. L. Chen, and R.D. Sanderson Heparanase regulates levels of syndecan-1 in the nucleus PLoS One 4 2009 e4947
64. N. Ilan, M. Elkin, and I. Vlodavsky Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis Int. J. Biochem. Cell Biol. 38 2006 2018 2039
65. I. Vlodavsky, G. Abboud-Jarrous, M. Elkin, A. Naggi, B. Casu, R. Sasisekharan, and N. Ilan The impact of heparanese and heparin on cancer metastasis and angiogenesis Pathophysiol. Haemost. Thromb. 35 2006 116 127
66. P. Beckhove Vlodavsky, I. Lerner, C. Pisano, A. Meirovitz, N. Ilan, and M. Elkin Significance of heparanase in cancer and inflammation Cancer Microenviron. 2011
67. I. Vlodavsky, A. Eldor, M. Bar-Ner, R. Fridman, I.R. Cohen, and M. Klagsbrun Heparan sulfate degradation in tumor cell invasion and angiogenesis Adv. Exp. Med. Biol. 233 1988 201 210
68. T. Ohkawa, Y. Naomoto, M. Takaoka, T. Nobuhisa, K. Noma, T. Motoki, T. Murata, H. Uetsuka, M. Kobayashi, Y. Shirakawa, T. Yamatsuji, N. Matsubara, J. Matsuoka, M. Haisa, M. Gunduz, H. Tsujigiwa, H. Nagatsuka, M. Hosokawa, M. Nakajima, and N. Tanaka Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation Lab. Invest. 84 2004 1289 1304
69. F. Zong, E. Fthenou, N. Wolmer, P.t. HollÃsi, I. Kovalszky, L.s. SzilÃk, C. Mogler, G. Nilsonne, G. Tzanakakis, and K. Dobra Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells PLoS One 4 2009 e7346
70. S.Y. Schubert, N. Ilan, M. Shushy, O. Ben-Izhak, I. Vlodavsky, and O. Goldshmidt Human heparanase nuclear localization and enzymatic activity Lab. Invest. 84 2004 535 544
71. T. Nobuhisa, Y. Naomoto, M. Takaoka, Y. Tabuchi, K. Ookawa, D. Kitamoto, E. Gunduz, M. Gunduz, H. Nagatsuka, M. Haisa, J. Matsuoka, M. Nakajima, and N. Tanaka Emergence of nuclear heparanase induces differentiation of human mammary cancer cells Biochem. Biophys. Res. Commun. 331 2005 175 180
72. A. Purushothaman, D.R. Hurst, C. Pisano, S. Mizumoto, K. Sugahara, and R.D. Sanderson Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype J. Biol. Chem. 2011
73. M. Keresztes, and J. Boonstra Import(ance) of growth factors in(to) the nucleus J. Cell Biol. 145 1999 421 424
74. D.A. Jans, and G. Hassan Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling? Bioessays 20 1998 400 411
75. S. Olsnes, O. Klingenberg, and A. Wiedlocha Transport of exogenous growth factors and cytokines to the cytosol and to the nucleus Physiol. Rev. 83 2003 163 182
76. K.A. Mislick, and J.D. Baldeschwieler Evidence for the role of proteoglycans in cation-mediated gene transfer Proc. Natl. Acad. Sci. U. S. A. 93 1996 12349 12354
77. M. Belting Heparan sulfate proteoglycan as a plasma membrane carrier Trends Biochem. Sci. 28 2003 145 151
78. S. Sandgren, A. Wittrup, F. Cheng, M. Jonsson, E. Eklund, S. Busch, and M. Belting The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis J. Biol. Chem. 279 2004 17951 17956
79. G.M. Poon, and J. Gariepy Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells Biochem. Soc. Trans. 35 2007 788 793
80. A. Wittrup, S. Sandgren, J. Lilja, C. Bratt, N. Gustavsson, M. Morgelin, and M. Belting Identification of proteins released by mammalian cells that mediate DNA internalization through proteoglycan-dependent macropinocytosis J. Biol. Chem. 282 2007 27897 27904
81. A. Wittrup, S.H. Zhang, G.B. ten Dam, T.H. van Kuppevelt, P. Bengtson, M. Johansson, J. Welch, M. Morgelin, and M. Belting ScFv antibody-induced translocation of cell-surface heparan sulfate proteoglycan to endocytic vesicles: evidence for heparan sulfate epitope specificity and role of both syndecan and glypican J. Biol. Chem. 284 2009 32959 32967
82. T. Letoha, A. Keller-Pinter, E. Kusz, C. Kolozsi, Z. Bozso, G. Toth, C. Vizler, Z. Olah, and L. Szilak Cell-penetrating peptide exploited syndecans Biochim. Biophys. Acta 1798 2010 2258 2265
83. A. Wittrup, S.H. Zhang, and M. Belting Studies of proteoglycan involvement in CPP-mediated delivery Methods Mol. Biol. 683 2011 99 115
84. M. Belting, S. Sandgren, and A. Wittrup Nuclear delivery of macromolecules: barriers and carriers Adv. Drug Deliv. Rev. 57 2005 505 527
85. H.C. Christianson, K.J. Svensson, T.H. van Kuppevelt, J.P. Li, and M. Belting Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity Proc. Natl. Acad. Sci. U. S. A. 110 2013 17380 17385
86. H.C. Christianson, and M. Belting Heparan sulfate proteoglycan as a cell-surface endocytosis receptor Matrix Biol. 2013
87. K. Chen, and K.J. Williams Molecular mediators for raft-dependent endocytosis of syndecan-1, a highly conserved, multifunctional receptor J. Biol. Chem. 288 2013 13988 13999
88. N. Quarto, and F. Amalric Heparan sulfate proteoglycans as transducers of FGF-2 signalling J. Cell Sci. 107 Pt 11 1994 3201 3212
89. V. Baldin, A.M. Roman, I. Bosc-Bierne, F. Amalric, and G. Bouche Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells EMBO J. 9 1990 1511 1517
90. D.M. Ornitz, A.B. Herr, M. Nilsson, J. Westman, C.M. Svahn, and G. Waksman FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides Science 268 1995 432 436
91. Z.X. Yu, S. Biro, Y.M. Fu, J. Sanchez, G. Smale, J. Sasse, V.J. Ferrans, and W. Casscells Localization of basic fibroblast growth factor in bovine endothelial cells: immunohistochemical and biochemical studies Exp. Cell Res. 204 1993 247 259
92. P.A. Maher Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2 J. Cell Biol. 134 1996 529 536
93. M. Roghani, and D. Moscatelli Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms J. Biol. Chem. 267 1992 22156 22162
94. F. Amalric, G. Bouche, H. Bonnet, P. Brethenou, A.M. Roman, I. Truchet, and N. Quarto Fibroblast growth factor-2 (FGF-2) in the nucleus: translocation process and targets Biochem. Pharmacol. 47 1994 111 115
95. P. Tatrai, K. Egedi, A. Somoracz, T.H. van Kuppevelt, G. Ten Dam, M. Lyon, J.A. Deakin, A. Kiss, Z. Schaff, and I. Kovalszky Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer J. Histochem. Cytochem. 58 2010 429 441
96. L. Zhang, P. Sullivan, J. Suyama, and D. Marchetti Epidermal growth factor-induced heparanase nucleolar localization augments DNA topoisomerase I activity in brain metastatic breast cancer Mol. Cancer Res. 8 2010 278 290
97. J. Dudas, G. Ramadori, T. Knittel, K. Neubauer, D. Raddatz, K. Egedy, and I. Kovalszky Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate Biochem. J. 350 Pt 1 2000 245 251
98. Y.P. Au, G. Dobrowolska, D.R. Morris, and A.W. Clowes Heparin decreases activator protein-1 binding to DNA in part by posttranslational modification of Jun B Circ. Res. 75 1994 15 22
99. P. Tatrai, J. Dudas, E. Batmunkh, M. Mathe, A. Zalatnai, Z. Schaff, G. Ramadori, and I. Kovalszky Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma Lab. Invest. 86 2006 1149 1160
100. K. Bailly, F. Soulet, D. Leroy, F. Amalric, and G. Bouche Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor FASEB J. 14 2000 333 344
101. J.A. Buczek-Thomas, E. Hsia, C.B. Rich, J.A. Foster, and M.A. Nugent Inhibition of histone acetyltransferase by glycosaminoglycans J. Cell. Biochem. 105 2008 108 120
102. A. Purushothaman, D.R. Hurst, C. Pisano, S. Mizumoto, K. Sugahara, and R.D. Sanderson Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype J. Biol. Chem. 286 2011 30377 30383
103. U. Nilsson, R. Johnsson, L.A. Fransson, U. Ellervik, and K. Mani Attenuation of tumor growth by formation of antiproliferative glycosaminoglycans correlates with low acetylation of histone H3 Cancer Res. 70 2010 3771 3779
104. F. Zong, E. Fthenou, J. Castro, B. Peterfia, I. Kovalszky, L. Szilak, G. Tzanakakis, and K. Dobra Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains Cell Prolif. 2009
105. K. Dobra, M. Nurminen, and A. Hjerpe Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells Anticancer Res. 23 2003 2435 2444
106. T. Szatmari, F. Mundt, G. Heidari-Hamedani, F. Zong, E. Ferolla, A. Alexeyenko, A. Hjerpe, and K. Dobra Novel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cells PLoS One 7 2012 e48091
107. S.M. Raja, S.S. Metkar, S. Honing, B. Wang, W.A. Russin, N.H. Pipalia, C. Menaa, M. Belting, X. Cao, R. Dressel, and C.J. Froelich A novel mechanism for protein delivery: granzyme B undergoes electrostatic exchange from serglycin to target cells J. Biol. Chem. 280 2005 20752 20761
108. M. Belting, and A. Wittrup Macromolecular drug delivery: basic principles and therapeutic applications Mol. Biotechnol. 43 2009 89 94
109. M. Belting, and A. Wittrup Developments in macromolecular drug delivery Methods Mol. Biol. 480 2009 1 10
110. U. Nilsson, R. Johnsson, L.A. Fransson, U. Ellervik, and K. Mani Attenuation of tumor growth by formation of antiproliferative glycosaminoglycans correlates with low acetylation of histone H3 Cancer Res. 70 2010 3771 3779
111. Y. Tsuzuki, T.K. Nguyen, D.R. Garud, B. Kuberan, and M. Koketsu 4-Deoxy-4-fluoro-xyloside derivatives as inhibitors of glycosaminoglycan biosynthesis Bioorg. Med. Chem. Lett. 20 2010 7269 7273
112. D.M. Beauvais, B.J. Ell, A.R. McWhorter, and A.C. Rapraeger Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor J. Exp. Med. 206 2009 691 705
113. V.C. Ramani, A. Purushothaman, M.D. Stewart, C.A. Thompson, I. Vlodavsky, J.L. Au, and R.D. Sanderson The heparanase/syndecan-1 axis in cancer: mechanisms and therapies FEBS J. 280 2013 2294 2306
114. N. Afratis, C. Gialeli, D. Nikitovic, T. Tsegenidis, E. Karousou, A.D. Theocharis, M.S. Pavao, G.N. Tzanakakis, and N.K. Karamanos Glycosaminoglycans: key players in cancer cell biology and treatment FEBS J. 279 2012 1177 1197